-
Signature
-
Brett Sandercock, Chief Financial Officer
-
Stock symbol
-
RMD
-
Transactions as of
-
Nov 3, 2025
-
Transactions value $
-
-$539,340
-
Form type
-
4
-
Date filed
-
11/4/2025, 04:02 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Sandercock Brett |
Chief Financial Officer |
RESMED INC., 9001 SPECTRUM CENTER BLVD., SAN DIEGO |
Brett Sandercock, Chief Financial Officer |
2025-11-04 |
0001346064 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RMD |
ResMed Common Stock |
Options Exercise |
$203K |
+2K |
+2.31% |
$101.64 |
88.7K |
Nov 3, 2025 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock |
Sale |
-$743K |
-3K |
-3.38% |
$247.54 |
85.7K |
Nov 3, 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RMD |
ResMed Common Stock Options |
Options Exercise |
$0 |
-2K |
-100% |
$0.00 |
0 |
Nov 3, 2025 |
ResMed Common Stock |
2K |
$101.64 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: